Jim A. Wright,Aiping H. Young,Yoon Lee,Ming Yu Cao
申请号：
US11817914
公开号：
US08287851B2
申请日:
2006.03.08
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The use of interleukin 17E to inhibit tumor growth in a subject is provided. The interleukin 17E can be provided to the subject exogenously, as an interleukin 17E polypeptide or a polynucleotide encoding an interleukin 17E polypeptide, or it can be provided by stimulating production of endogenous interleukin 17E. Also provided is the use of interleukin 17E in combination with one or more anti-cancer therapeutics for inhibiting tumor growth in a subject. Anti-cancer therapeutics include, for example, standard chemotherapeutic drugs, immunotherapeutics, radiation, gene therapy, hormone manipulation and antisense therapy.
